

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 6.90389482 |
| 2 | regulation of fibrinolysis (GO:0051917) | 6.48204568 |
| 3 | regulation of protein activation cascade (GO:2000257) | 6.31962709 |
| 4 | regulation of complement activation (GO:0030449) | 6.00487634 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.99796154 |
| 6 | protein carboxylation (GO:0018214) | 5.99796154 |
| 7 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.66424295 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.66113867 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.66113867 |
| 10 | regulation of cholesterol esterification (GO:0010872) | 5.60311815 |
| 11 | plasma lipoprotein particle assembly (GO:0034377) | 5.51323289 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.43985651 |
| 13 | plasma lipoprotein particle remodeling (GO:0034369) | 5.36390560 |
| 14 | protein-lipid complex remodeling (GO:0034368) | 5.36390560 |
| 15 | macromolecular complex remodeling (GO:0034367) | 5.36390560 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.29597570 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 5.29597570 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.24760311 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.21783211 |
| 20 | cholesterol efflux (GO:0033344) | 5.19238534 |
| 21 | negative regulation of cholesterol transport (GO:0032375) | 5.08952904 |
| 22 | negative regulation of sterol transport (GO:0032372) | 5.08952904 |
| 23 | reverse cholesterol transport (GO:0043691) | 5.01927728 |
| 24 | low-density lipoprotein particle remodeling (GO:0034374) | 4.99720009 |
| 25 | protein-lipid complex assembly (GO:0065005) | 4.97402587 |
| 26 | intestinal cholesterol absorption (GO:0030299) | 4.88936505 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 4.84993821 |
| 28 | plasma lipoprotein particle organization (GO:0071827) | 4.60263711 |
| 29 | phospholipid efflux (GO:0033700) | 4.57690544 |
| 30 | regulation of plasminogen activation (GO:0010755) | 4.53102575 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.40464887 |
| 32 | protein-lipid complex subunit organization (GO:0071825) | 4.36371181 |
| 33 | ethanol oxidation (GO:0006069) | 4.28194146 |
| 34 | regulation of apoptotic cell clearance (GO:2000425) | 4.11987971 |
| 35 | plasma lipoprotein particle clearance (GO:0034381) | 4.08553146 |
| 36 | glutamate metabolic process (GO:0006536) | 4.07951719 |
| 37 | glyoxylate metabolic process (GO:0046487) | 4.07600380 |
| 38 | fibrinolysis (GO:0042730) | 4.05530393 |
| 39 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.00222247 |
| 40 | regulation of bile acid biosynthetic process (GO:0070857) | 3.88301929 |
| 41 | negative regulation of protein activation cascade (GO:2000258) | 3.87404197 |
| 42 | exogenous drug catabolic process (GO:0042738) | 3.81774315 |
| 43 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77020143 |
| 44 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77020143 |
| 45 | protein activation cascade (GO:0072376) | 3.74900217 |
| 46 | drug catabolic process (GO:0042737) | 3.71057056 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 3.68959809 |
| 48 | negative regulation of lipase activity (GO:0060192) | 3.68708402 |
| 49 | urea metabolic process (GO:0019627) | 3.67825735 |
| 50 | triglyceride homeostasis (GO:0070328) | 3.64768187 |
| 51 | acylglycerol homeostasis (GO:0055090) | 3.64768187 |
| 52 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.64753857 |
| 53 | negative regulation of blood coagulation (GO:0030195) | 3.63687242 |
| 54 | negative regulation of hemostasis (GO:1900047) | 3.63687242 |
| 55 | acute-phase response (GO:0006953) | 3.62069726 |
| 56 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.61077308 |
| 57 | proline metabolic process (GO:0006560) | 3.53244762 |
| 58 | aromatic amino acid family catabolic process (GO:0009074) | 3.51131575 |
| 59 | complement activation, classical pathway (GO:0006958) | 3.50361686 |
| 60 | omega-hydroxylase P450 pathway (GO:0097267) | 3.48989248 |
| 61 | intestinal absorption (GO:0050892) | 3.48666906 |
| 62 | cellular glucuronidation (GO:0052695) | 3.44451647 |
| 63 | regulation of humoral immune response (GO:0002920) | 3.44036501 |
| 64 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.39020723 |
| 65 | ethanol metabolic process (GO:0006067) | 3.36128921 |
| 66 | lipoprotein metabolic process (GO:0042157) | 3.34621665 |
| 67 | urea cycle (GO:0000050) | 3.34196371 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 3.32282457 |
| 69 | positive regulation of hemostasis (GO:1900048) | 3.32282457 |
| 70 | bile acid metabolic process (GO:0008206) | 3.30238712 |
| 71 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.29982426 |
| 72 | negative regulation of coagulation (GO:0050819) | 3.29538295 |
| 73 | serine family amino acid catabolic process (GO:0009071) | 3.27729186 |
| 74 | axon ensheathment in central nervous system (GO:0032291) | 3.27453442 |
| 75 | central nervous system myelination (GO:0022010) | 3.27453442 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 3.26750344 |
| 77 | cholesterol homeostasis (GO:0042632) | 3.26555240 |
| 78 | cholesterol transport (GO:0030301) | 3.25549250 |
| 79 | sterol transport (GO:0015918) | 3.25549250 |
| 80 | glucuronate metabolic process (GO:0019585) | 3.24265422 |
| 81 | uronic acid metabolic process (GO:0006063) | 3.24265422 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 3.22721595 |
| 83 | negative regulation of wound healing (GO:0061045) | 3.22170253 |
| 84 | sterol homeostasis (GO:0055092) | 3.21319527 |
| 85 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.20207902 |
| 86 | complement activation (GO:0006956) | 3.18331413 |
| 87 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.17817852 |
| 88 | positive regulation of steroid metabolic process (GO:0045940) | 3.09949532 |
| 89 | positive regulation of extracellular matrix organization (GO:1903055) | 3.05232891 |
| 90 | regulation of cholesterol metabolic process (GO:0090181) | 3.04539452 |
| 91 | positive regulation of coagulation (GO:0050820) | 3.03409588 |
| 92 | cellular sodium ion homeostasis (GO:0006883) | 3.03235424 |
| 93 | regulation of triglyceride catabolic process (GO:0010896) | 3.02951770 |
| 94 | drug metabolic process (GO:0017144) | 3.02604274 |
| 95 | bile acid and bile salt transport (GO:0015721) | 3.00179032 |
| 96 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.98676096 |
| 97 | phospholipid homeostasis (GO:0055091) | 2.95660720 |
| 98 | C4-dicarboxylate transport (GO:0015740) | 2.95462077 |
| 99 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.93185866 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 2.93129903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.39431066 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.27799250 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.66517555 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.48611583 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.07592853 |
| 6 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.98290288 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.90073324 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85451540 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.67419792 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.55186040 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.53820661 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.28081839 |
| 13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.11447403 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.87991547 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86692424 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85323810 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82312054 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.81798385 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78053550 |
| 20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.72914433 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72679146 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70294523 |
| 23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.68397192 |
| 24 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66260646 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.65555115 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.64312378 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.62681469 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55758081 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51375951 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51375951 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.50575395 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.46740751 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46739531 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.39769611 |
| 35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36626440 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35984300 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33990732 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33010211 |
| 39 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.31232427 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28570817 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27663062 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25707097 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25520492 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25169698 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24685370 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23511427 |
| 47 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23456645 |
| 48 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.22040634 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21849750 |
| 50 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.18569135 |
| 51 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17534491 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17377642 |
| 53 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15923381 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12464759 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11166672 |
| 56 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.08176412 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05434498 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.05376591 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04386715 |
| 60 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04034346 |
| 61 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03237572 |
| 62 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.02168942 |
| 63 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.00357782 |
| 64 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99757073 |
| 65 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99455420 |
| 66 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98166458 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98157391 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96503539 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96330404 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94632562 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.93619201 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93576985 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93341849 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92446125 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91892562 |
| 76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91407425 |
| 77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90243828 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88354332 |
| 79 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87672117 |
| 80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87227110 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85893927 |
| 82 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.84615558 |
| 83 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82866833 |
| 84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.81263863 |
| 85 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.80351819 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.80022873 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79966123 |
| 88 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79515600 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78965213 |
| 90 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78159563 |
| 91 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77322826 |
| 92 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.76502879 |
| 93 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75450223 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.75127769 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74282217 |
| 96 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.73451087 |
| 97 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.70790972 |
| 98 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.69507084 |
| 99 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69474660 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.68945796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.00703461 |
| 2 | MP0005360_urolithiasis | 5.33109987 |
| 3 | MP0005365_abnormal_bile_salt | 4.76453111 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.48298985 |
| 5 | MP0003195_calcinosis | 3.77073478 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.54388540 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.53468115 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.45167879 |
| 9 | MP0003122_maternal_imprinting | 3.17383010 |
| 10 | MP0000566_synostosis | 2.82379890 |
| 11 | MP0004270_analgesia | 2.70094595 |
| 12 | MP0003868_abnormal_feces_composition | 2.66084000 |
| 13 | MP0003252_abnormal_bile_duct | 2.58197798 |
| 14 | MP0009840_abnormal_foam_cell | 2.07844958 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 1.93571155 |
| 16 | MP0005332_abnormal_amino_acid | 1.89931475 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 1.87535904 |
| 18 | MP0002089_abnormal_postnatal_growth/wei | 1.87381395 |
| 19 | MP0003329_amyloid_beta_deposits | 1.85503525 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.79241521 |
| 21 | MP0003690_abnormal_glial_cell | 1.69508900 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.66517953 |
| 23 | MP0003123_paternal_imprinting | 1.63617245 |
| 24 | MP0003879_abnormal_hair_cell | 1.63210329 |
| 25 | MP0002064_seizures | 1.58260351 |
| 26 | MP0000604_amyloidosis | 1.52160274 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.49142509 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.42679227 |
| 29 | MP0000920_abnormal_myelination | 1.38766273 |
| 30 | MP0000609_abnormal_liver_physiology | 1.38417727 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.36299587 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.34971358 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.25588531 |
| 34 | MP0005409_darkened_coat_color | 1.24900593 |
| 35 | MP0001486_abnormal_startle_reflex | 1.23843690 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.23108861 |
| 37 | MP0003633_abnormal_nervous_system | 1.22373026 |
| 38 | MP0003632_abnormal_nervous_system | 1.19827474 |
| 39 | MP0003880_abnormal_central_pattern | 1.15548326 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.15446517 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.14953057 |
| 42 | MP0003136_yellow_coat_color | 1.13813894 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.13253325 |
| 44 | MP0005408_hypopigmentation | 1.12472689 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.11335961 |
| 46 | MP0003631_nervous_system_phenotype | 1.11095602 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.07275371 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.04736998 |
| 49 | MP0009745_abnormal_behavioral_response | 1.04452910 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.01542505 |
| 51 | MP0001915_intracranial_hemorrhage | 1.01156746 |
| 52 | MP0005058_abnormal_lysosome_morphology | 0.99974357 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 0.97518131 |
| 54 | MP0002272_abnormal_nervous_system | 0.95802468 |
| 55 | MP0002572_abnormal_emotion/affect_behav | 0.95137146 |
| 56 | MP0000639_abnormal_adrenal_gland | 0.93112012 |
| 57 | MP0008569_lethality_at_weaning | 0.89328486 |
| 58 | MP0002557_abnormal_social/conspecific_i | 0.88571283 |
| 59 | MP0004885_abnormal_endolymph | 0.85264713 |
| 60 | MP0009046_muscle_twitch | 0.83755943 |
| 61 | MP0001764_abnormal_homeostasis | 0.83100925 |
| 62 | MP0002249_abnormal_larynx_morphology | 0.81128599 |
| 63 | MP0003634_abnormal_glial_cell | 0.76837214 |
| 64 | MP0009643_abnormal_urine_homeostasis | 0.73504281 |
| 65 | MP0002822_catalepsy | 0.73377031 |
| 66 | MP0003121_genomic_imprinting | 0.73165323 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.72092567 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70672927 |
| 69 | MP0002971_abnormal_brown_adipose | 0.69946422 |
| 70 | MP0009642_abnormal_blood_homeostasis | 0.69793747 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 0.67589018 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.67516722 |
| 73 | MP0005670_abnormal_white_adipose | 0.67303308 |
| 74 | MP0001756_abnormal_urination | 0.67151307 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 0.66961417 |
| 76 | MP0003878_abnormal_ear_physiology | 0.66961417 |
| 77 | MP0001440_abnormal_grooming_behavior | 0.66889789 |
| 78 | MP0009697_abnormal_copulation | 0.66286354 |
| 79 | MP0000598_abnormal_liver_morphology | 0.66020492 |
| 80 | MP0005451_abnormal_body_composition | 0.65809014 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.65741138 |
| 82 | MP0000955_abnormal_spinal_cord | 0.65426531 |
| 83 | MP0005448_abnormal_energy_balance | 0.65126619 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.64070348 |
| 85 | MP0004742_abnormal_vestibular_system | 0.63621774 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.63489614 |
| 87 | MP0003953_abnormal_hormone_level | 0.62285674 |
| 88 | MP0001984_abnormal_olfaction | 0.60845050 |
| 89 | MP0001968_abnormal_touch/_nociception | 0.60788733 |
| 90 | MP0003075_altered_response_to | 0.59121476 |
| 91 | MP0002067_abnormal_sensory_capabilities | 0.57339899 |
| 92 | MP0000778_abnormal_nervous_system | 0.56181709 |
| 93 | MP0005187_abnormal_penis_morphology | 0.56143747 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.56078600 |
| 95 | MP0002132_abnormal_respiratory_system | 0.54933348 |
| 96 | MP0004043_abnormal_pH_regulation | 0.53883553 |
| 97 | MP0002229_neurodegeneration | 0.53819648 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.53341506 |
| 99 | MP0004924_abnormal_behavior | 0.53341506 |
| 100 | MP0002066_abnormal_motor_capabilities/c | 0.53152236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.96305590 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 7.41067102 |
| 3 | Complement deficiency (HP:0004431) | 7.17078599 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.72265672 |
| 5 | Joint hemorrhage (HP:0005261) | 6.06671727 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.84635839 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.77821638 |
| 8 | Abnormality of complement system (HP:0005339) | 5.41978945 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 4.84488706 |
| 10 | Xanthomatosis (HP:0000991) | 4.76079061 |
| 11 | Glomerulonephritis (HP:0000099) | 4.75709548 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.66932789 |
| 13 | Spontaneous abortion (HP:0005268) | 4.54260755 |
| 14 | Conjugated hyperbilirubinemia (HP:0002908) | 4.17297422 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.05547002 |
| 16 | Hypercholesterolemia (HP:0003124) | 3.63799376 |
| 17 | Hemorrhage of the eye (HP:0011885) | 3.46695749 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.45336862 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.28733050 |
| 20 | Epidermoid cyst (HP:0200040) | 3.23851872 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.10344546 |
| 22 | Vascular calcification (HP:0004934) | 3.03136793 |
| 23 | Fat malabsorption (HP:0002630) | 2.95793653 |
| 24 | Nephritis (HP:0000123) | 2.78145288 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.77806154 |
| 26 | Menorrhagia (HP:0000132) | 2.77729788 |
| 27 | Mitral stenosis (HP:0001718) | 2.77402718 |
| 28 | Osteomalacia (HP:0002749) | 2.69197129 |
| 29 | Gingival bleeding (HP:0000225) | 2.68231491 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.66757877 |
| 31 | Acanthocytosis (HP:0001927) | 2.63216067 |
| 32 | Cardiovascular calcification (HP:0011915) | 2.58218456 |
| 33 | Hyperglycinemia (HP:0002154) | 2.47736016 |
| 34 | Abnormality of carpal bone ossification (HP:0006257) | 2.45453374 |
| 35 | Bronchomalacia (HP:0002780) | 2.45131179 |
| 36 | Hepatoblastoma (HP:0002884) | 2.43711702 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 2.41033506 |
| 38 | Purpura (HP:0000979) | 2.39732950 |
| 39 | Alacrima (HP:0000522) | 2.39535204 |
| 40 | Abnormal tarsal ossification (HP:0008369) | 2.37842682 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.35929071 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 2.35929071 |
| 43 | Arthropathy (HP:0003040) | 2.28884880 |
| 44 | Hyperglycinuria (HP:0003108) | 2.27500375 |
| 45 | Bifid scrotum (HP:0000048) | 2.21843261 |
| 46 | Hypophosphatemic rickets (HP:0004912) | 2.21547557 |
| 47 | Focal motor seizures (HP:0011153) | 2.19911220 |
| 48 | Hydroxyprolinuria (HP:0003080) | 2.17726647 |
| 49 | Abnormality of proline metabolism (HP:0010907) | 2.17726647 |
| 50 | Flat acetabular roof (HP:0003180) | 2.15784051 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.13584230 |
| 52 | Rickets (HP:0002748) | 2.12792557 |
| 53 | Potter facies (HP:0002009) | 2.11752791 |
| 54 | Facial shape deformation (HP:0011334) | 2.11752791 |
| 55 | Retinal atrophy (HP:0001105) | 2.10382895 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.10015533 |
| 57 | Thrombophlebitis (HP:0004418) | 2.08067626 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07381928 |
| 59 | Abnormality of the nasal septum (HP:0000419) | 2.04137036 |
| 60 | Abnormal hand bone ossification (HP:0010660) | 2.03143216 |
| 61 | Neonatal short-limb short stature (HP:0008921) | 2.01075584 |
| 62 | Epileptic encephalopathy (HP:0200134) | 1.99967232 |
| 63 | Status epilepticus (HP:0002133) | 1.96574025 |
| 64 | Hyperammonemia (HP:0001987) | 1.96310253 |
| 65 | Action tremor (HP:0002345) | 1.94090709 |
| 66 | Abnormal ossification of hand bones (HP:0005921) | 1.93504797 |
| 67 | Skin nodule (HP:0200036) | 1.91705379 |
| 68 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.90796995 |
| 69 | Small epiphyses (HP:0010585) | 1.90346768 |
| 70 | Broad alveolar ridges (HP:0000187) | 1.89508843 |
| 71 | Amyloidosis (HP:0011034) | 1.87669182 |
| 72 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.82579211 |
| 73 | Aplasia of the phalanges of the hand (HP:0009802) | 1.82579211 |
| 74 | Aplasia involving bones of the extremities (HP:0009825) | 1.82579211 |
| 75 | Hypoglycemic coma (HP:0001325) | 1.80810568 |
| 76 | Myokymia (HP:0002411) | 1.80405281 |
| 77 | Megalencephaly (HP:0001355) | 1.78564002 |
| 78 | Widely patent fontanelles and sutures (HP:0004492) | 1.75122389 |
| 79 | Increased serum pyruvate (HP:0003542) | 1.73927816 |
| 80 | Focal seizures (HP:0007359) | 1.73534274 |
| 81 | Abnormality of the lumbar spine (HP:0100712) | 1.73095221 |
| 82 | Scanning speech (HP:0002168) | 1.72694202 |
| 83 | Decreased lacrimation (HP:0000633) | 1.72588883 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 1.72007293 |
| 85 | Impaired pain sensation (HP:0007328) | 1.71952313 |
| 86 | Abnormality of pain sensation (HP:0010832) | 1.71952313 |
| 87 | Enlarged kidneys (HP:0000105) | 1.66777342 |
| 88 | Steatorrhea (HP:0002570) | 1.66085178 |
| 89 | Delayed CNS myelination (HP:0002188) | 1.65741788 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 1.64807821 |
| 91 | Abnormality of glycolysis (HP:0004366) | 1.61442427 |
| 92 | Vaginal fistula (HP:0004320) | 1.60274108 |
| 93 | Neonatal death (HP:0003811) | 1.57721857 |
| 94 | Paraparesis (HP:0002385) | 1.56516571 |
| 95 | Atonic seizures (HP:0010819) | 1.56258708 |
| 96 | Pigmentary retinal degeneration (HP:0001146) | 1.55774504 |
| 97 | Broad palm (HP:0001169) | 1.55273081 |
| 98 | Partial duplication of thumb phalanx (HP:0009944) | 1.54505803 |
| 99 | Myocardial infarction (HP:0001658) | 1.53598240 |
| 100 | Poikilocytosis (HP:0004447) | 1.52443782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 5.07562319 |
| 2 | FGFR3 | 3.39425669 |
| 3 | EPHA4 | 3.26163803 |
| 4 | NTRK3 | 3.25981282 |
| 5 | TYRO3 | 3.04098895 |
| 6 | CASK | 2.77445966 |
| 7 | RIPK1 | 2.77408994 |
| 8 | ICK | 2.76425399 |
| 9 | NTRK2 | 2.52382336 |
| 10 | FGFR2 | 2.49523729 |
| 11 | MARK1 | 2.12635553 |
| 12 | WNK4 | 2.01961473 |
| 13 | SGK223 | 1.78917989 |
| 14 | SGK494 | 1.78917989 |
| 15 | PIK3CA | 1.76679412 |
| 16 | PDGFRA | 1.71988636 |
| 17 | NTRK1 | 1.70759028 |
| 18 | TRIB3 | 1.68733452 |
| 19 | SIK2 | 1.57977746 |
| 20 | DAPK2 | 1.42752905 |
| 21 | PRKD3 | 1.41482549 |
| 22 | FGFR1 | 1.40104799 |
| 23 | ERN1 | 1.38634865 |
| 24 | SGK2 | 1.32594899 |
| 25 | RET | 1.30403547 |
| 26 | LMTK2 | 1.29444729 |
| 27 | UHMK1 | 1.28738156 |
| 28 | ERBB2 | 1.28719647 |
| 29 | SIK1 | 1.26457565 |
| 30 | MAPK15 | 1.26373094 |
| 31 | LATS2 | 1.23415121 |
| 32 | PAK6 | 1.19727274 |
| 33 | PNCK | 1.18653033 |
| 34 | MAP3K2 | 1.17364548 |
| 35 | PDPK1 | 1.15950150 |
| 36 | SGK3 | 1.14600316 |
| 37 | CAMKK1 | 1.14242298 |
| 38 | KSR2 | 1.11856613 |
| 39 | PRKCG | 1.09283682 |
| 40 | MINK1 | 1.06127498 |
| 41 | SGK1 | 1.01793415 |
| 42 | AKT3 | 1.01263013 |
| 43 | DYRK1B | 0.97147027 |
| 44 | STK39 | 0.96379250 |
| 45 | CDK12 | 0.93873051 |
| 46 | MAP3K9 | 0.92699509 |
| 47 | EEF2K | 0.90969206 |
| 48 | MAPK11 | 0.90667891 |
| 49 | WNK1 | 0.88038545 |
| 50 | PRKAA2 | 0.86834362 |
| 51 | PDK1 | 0.83619116 |
| 52 | CDK5 | 0.83017336 |
| 53 | DDR2 | 0.80670665 |
| 54 | PRKCZ | 0.74845472 |
| 55 | CAMK1D | 0.74150373 |
| 56 | PRKACG | 0.73029676 |
| 57 | EPHA2 | 0.71804116 |
| 58 | CAMK2B | 0.71616437 |
| 59 | CAMK1G | 0.70711644 |
| 60 | RPS6KB1 | 0.70160527 |
| 61 | MAP2K4 | 0.67250258 |
| 62 | PHKG2 | 0.64429643 |
| 63 | PHKG1 | 0.64429643 |
| 64 | PRKAA1 | 0.63451887 |
| 65 | BRSK1 | 0.63400245 |
| 66 | EPHA3 | 0.62334477 |
| 67 | CSNK1E | 0.61368781 |
| 68 | NEK6 | 0.61081331 |
| 69 | CAMK2G | 0.55939862 |
| 70 | MARK2 | 0.54583036 |
| 71 | MET | 0.53603164 |
| 72 | LATS1 | 0.53337244 |
| 73 | RPS6KA3 | 0.52733153 |
| 74 | PKN2 | 0.51558001 |
| 75 | MAPK10 | 0.50742180 |
| 76 | MAPK13 | 0.50679265 |
| 77 | CDK15 | 0.50114818 |
| 78 | STK38 | 0.50075701 |
| 79 | SRC | 0.49529655 |
| 80 | MAPKAPK3 | 0.48627409 |
| 81 | CSNK1D | 0.46055559 |
| 82 | DAPK1 | 0.44461879 |
| 83 | CDK11A | 0.44180775 |
| 84 | PKN1 | 0.42757884 |
| 85 | CDK18 | 0.42540944 |
| 86 | PTK6 | 0.42274574 |
| 87 | CAMK4 | 0.41365494 |
| 88 | PRKG1 | 0.41261372 |
| 89 | CAMK2D | 0.40376494 |
| 90 | PINK1 | 0.39161930 |
| 91 | MAPKAPK5 | 0.39115280 |
| 92 | MAP3K1 | 0.37556092 |
| 93 | DYRK1A | 0.37384678 |
| 94 | MST1R | 0.36322916 |
| 95 | PRKG2 | 0.36254986 |
| 96 | CAMK2A | 0.35357745 |
| 97 | ALK | 0.33262332 |
| 98 | FYN | 0.32529686 |
| 99 | CDK14 | 0.31910434 |
| 100 | MAP2K6 | 0.31232022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.29035316 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.76092381 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95664851 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76044976 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58401873 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.46924932 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.42944032 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.37598374 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.31212901 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29525121 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22629072 |
| 12 | Retinol metabolism_Homo sapiens_hsa00830 | 2.19162861 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 2.14639730 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.14380884 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00060911 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95630289 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.95037772 |
| 18 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.93730178 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93284288 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91950652 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.83000102 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.82644606 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.82475089 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.79062651 |
| 25 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.70613789 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62911975 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54805106 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.51389585 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48262513 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47087362 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45049030 |
| 32 | Prion diseases_Homo sapiens_hsa05020 | 1.38822260 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31847915 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27832205 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23557314 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20732060 |
| 37 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09499226 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09025342 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.07949398 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07046469 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06028110 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.05805516 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.01059457 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99668440 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98545925 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92319597 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.80848954 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78795077 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75927051 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74709024 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74655963 |
| 52 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74083784 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73456259 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.71748862 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70136861 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68362097 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62103247 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60260064 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60187534 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58619642 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.55901016 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53800348 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53344894 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51455170 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51218046 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50835905 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50769126 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49638002 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49546488 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 0.48631224 |
| 71 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48415063 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48400630 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48365341 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47411313 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.47324609 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40591772 |
| 77 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39819620 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34981379 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.34755001 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.33660906 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29534533 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.29441845 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.29334405 |
| 84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28392665 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28103193 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28083818 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27110771 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26380654 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.26009998 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25755725 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24207058 |
| 92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23849224 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23526218 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.23018706 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.22628821 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19346408 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.18292675 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14292316 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.14126343 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13785006 |

